Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02855125
Title A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | FRA | ESP

Facility Status City State Zip Country Details
Loma Linda California United States Details
Gainesville Florida United States Details
Cleveland Ohio United States Details
Portland Oregon United States Details
Dallas Texas United States Details
Seattle Washington United States Details
Caen France Details
Lille France Details
Marseille France Details
Paris France Details
Pierre-Bénite France Details
Villejuif France Details
Catania Italy Details
Milano Italy Details
Palermo Italy Details
Ravenna Italy Details
Kashiwa Chiba Japan Details
Osakasayama Osaka 589-8511 Japan Details
Adachi Saitama 362-0806 Japan Details
Chuo-Ku Tokyo Japan Details
Koto-Ku Tokyo 135-8550 Japan Details
Sunto-Gun Tokyo Japan Details
Wakayama 641-8509 Japan Details
Katowice Poland Details
Lodz Poland Details
Lublin Poland Details
Warszawa Poland Details
Badalona Spain Details
Barcelona Spain Details
Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field